XML 87 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Combined Statements of Cash Flows (Predecessor) (Ziegler Healthcare Real Estate Funds, USD $)
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Ziegler Healthcare Real Estate Funds
   
Cash Flows from Operating Activities    
Net loss $ (584,427) $ (567,643)
Adjustments to reconcile net loss to net cash provided by operating activities    
Depreciation and amortization 2,060,492 2,300,567
Gain on sale of investment properties   (340,173)
Loss on sale of property under development   66,853
Lease Inducement 35,000 35,000
Change in Fair Value of Derivatives, net (189,688) (58,138)
Provision for bad debts 29,522 121,113
(Increase) decrease in    
Tenant receivables 98,171 322,262
Deferred costs (38,770) (96,868)
Other assets (738,763) (492,137)
Increase (decrease) in    
Accounts payable to related parties 384,394 378,514
Accounts payable (269,676) (187,314)
Accrued expenses and other liabilities 240,916 160,228
Total Adjustments 1,611,598 2,209,907
Net Cash Provided by Operating Activities 1,027,171 1,642,264
Cash Flows from Investing Activities    
Proceeds from sale of investment properties   5,547,620
Capital expenditures on investment properties (267,896) (470,901)
Net Cash (Used in ) Provided by Investing Activities (267,896) 5,076,719
Cash Flows from Financing Activities    
Payments on notes payable (857,421) (5,902,274)
Proceeds from issuance of debt 163,491  
Distributions to members and partners (140,375) (637,375)
Contributions to noncontrolling interest   303,783
Distributions to noncontrolling interest (172,954) (416,499)
Net Cash Used in Financing Activities (1,007,259) (6,652,365)
Net (Decrease) Increase in Cash and Cash Equivalents (247,984) 66,618
Cash and Cash Equivalents, Beginning of Year 2,614,036 1,931,885
Cash and Cash Equivalents, End of Period 2,366,052 1,998,503
Supplemental Disclosure of Cash Flow Information Interest paid during the year $ 2,130,894 $ 2,295,273